Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 23;16(29):13459-13467.
doi: 10.1039/d5sc02844b. eCollection 2025 Jul 23.

Stereoselective chemoenzymatic phytate transformations provide access to diverse inositol phosphate derivatives

Affiliations

Stereoselective chemoenzymatic phytate transformations provide access to diverse inositol phosphate derivatives

Georg Markus Häner et al. Chem Sci. .

Abstract

Phosphorylated myo-inositols (InsPs) are essential cytoplasmic signaling molecules, while their lipidated analogs (PtdInsPs) play a crucial role in membrane signaling. Stereoselective synthesis of these compounds has been achieved through various methods, predominantly using the meso compound myo-inositol as a starting material. However, phytate (InsP6), also a meso compound, is the most abundant inositol derivative in plants - far more prevalent than myo-inositol itself. Despite its abundance, phytate has been rarely used in synthetic strategies for accessing a variety of chiral inositol phosphates and their derivatives through selective dephosphorylations on a preparative scale. Here, we report gram-scale (stereo)selective dephosphorylations of phytate using phytases and demonstrate the application of these products in generating modified InsPs through a transient phosphitylation approach. Notably, the bacterial effector XopH efficiently desymmetrizes meso-phytate to yield enantiomerically pure 1-OH-InsP5. This transformation renders the 1-position accessible for further modifications, which, in biological systems, is where glycerolphosphate diesters are attached. By using selective dephosphorylations with phytases in concert with chemoselective telescoping reaction sequences, this approach greatly advances the stereoselective synthesis of inositol phosphates and their derivatives, such as glycerophosphoinositols, from abundant InsP6.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts to declare.

Figures

Scheme 1
Scheme 1. Desymmetrization of phytate via selective dephosphorylation using phytases. Previously, 1,2,6-InsP3 was obtained by baker's yeast digest. Here, selective dephosphorylation with expressed XopH on a preparative scale was established. The resulting chiral 1-OH-InsP5 was transformed into the corresponding chiral 1-InsP1 chemoenzymatically with the phytase Natuphos, thus inverting the phosphorylation pattern.
Scheme 2
Scheme 2. Synthesis of 1-OH-InsP52via selective dephosphorylation of InsP6 with XopH.
Scheme 3
Scheme 3. Synthesis of InsP6 derivatives modified solely at the 1-position. CE-qTOF-MS (background electrolyte (in the following BGE): NH4OAc 35 mM pH = 9.7, CE voltage: 30 kV, CE current: 23 μA, injection: 100 mbar, 15 s (30 nL)) analysis of the transient phosphitylation of 1-OH-InsP5 using different P-amidites. The depicted structures are color coded by identical mass. (a) Using P-amidite 1 a complex mixture was obtained. (b) Reduction of components was achieved via controlled cyclization using cyclization prone P-amidite 9. The depicted cyclic pyrophosphates are just examples of possible structures. (c) The obtained cyclic intermediates were transformed into a single product in situ via subsequent acid treatment. (d) Using an optimized transient phosphitylation work-flow 1-Fm-InsP68 and 1-DEACM-InsP611 were synthesized in one telescoping reaction sequence starting from 1-OH-InsP5.
Scheme 4
Scheme 4. Dephosphorylation of InsP6 derivatives with Natuphos (10500 U mL−1, 3150 U was used for the digest of phytate, 2100 U was used for the digest of 8) in NH4OAc (50 mM, pH 6.3) leads to defined InsP1 isomers. 1,2-InsP2 was obtained as dephosphorylation product of 1-Fm-InsP68 using the 6-Phytase from E. coli (7500 U mL−1, 1 U phytase was used) in HEPES-buffer (50 mM HEPES, 10 mM NaCl, 5% glycerol, 2 mM DTT, 0.5 mM, MgCl2, pH = 4.0; at 28 °C for 45 min) and subsequent basic deprotection.
Scheme 5
Scheme 5. (a) Different InsP6 (15 mM) were dephosphorylated with 6-phytase from Escherichia coli (7500 U mL−1 at pH = 5.0, 1 U phytase was used) (used buffer: 50 mM HEPES, 10 mM NaCl, 5% glycerol, 2 mM DTT, 0.5 mM, MgCl2, pH = 4.0; at 28 °C for 45 min). CE-qTOF-MS (BGE: NH4OAc 35 mM pH = 9.7, CE voltage: 30 kV, CE current: 23 μA, injection: 100 mbar, 15 s (30 nL)). (b) Analysis revealed different InsPs as product mixtures, depending on the used InsP6 derivative. 1-Fm-InsP68 was relatively cleanly dephosphorylated to an InsP2 derivative. (c) The formed 1,2-InsP2 was identified via CE-QQQ-MS (BGE: NH4OAc 35 mM pH = 9.7, CE voltage: 30 kV, CE current: 23 μA, injection: 100 mbar, 10 s (20 nL)) spiking experiments using a [13C]-InsP2 mix (obtained via decomposition of [13C]-InsP6 at 100 °C), after basic deprotection (piperidine (10 vol%)) of 1-Fm-InsP218.
Scheme 6
Scheme 6. Synthesis of 1-GroPIns 21 and the non-natural 2-GroPIns derivative 20via Co(iii) catalyzed epoxide ring opening of S-(−)-glycidol with InsP1 isomers.

Similar articles

  • Management of urinary stones by experts in stone disease (ESD 2025).
    Papatsoris A, Geavlete B, Radavoi GD, Alameedee M, Almusafer M, Ather MH, Budia A, Cumpanas AA, Kiremi MC, Dellis A, Elhowairis M, Galán-Llopis JA, Geavlete P, Guimerà Garcia J, Isern B, Jinga V, Lopez JM, Mainez JA, Mitsogiannis I, Mora Christian J, Moussa M, Multescu R, Oguz Acar Y, Petkova K, Piñero A, Popov E, Ramos Cebrian M, Rascu S, Siener R, Sountoulides P, Stamatelou K, Syed J, Trinchieri A. Papatsoris A, et al. Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
  • Short-Term Memory Impairment.
    Cascella M, Al Khalili Y. Cascella M, et al. 2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31424720 Free Books & Documents.
  • Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
    Struyf T, Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Leeflang MM, Spijker R, Hooft L, Emperador D, Domen J, Tans A, Janssens S, Wickramasinghe D, Lannoy V, Horn SRA, Van den Bruel A; Cochrane COVID-19 Diagnostic Test Accuracy Group. Struyf T, et al. Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
  • The Black Book of Psychotropic Dosing and Monitoring.
    DeBattista C, Schatzberg AF. DeBattista C, et al. Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
  • Organic Synthesis Away from Equilibrium: Contrathermodynamic Transformations Enabled by Excited-State Electron Transfer.
    Lin A, Lee S, Knowles RR. Lin A, et al. Acc Chem Res. 2024 Jul 2;57(13):1827-1838. doi: 10.1021/acs.accounts.4c00227. Epub 2024 Jun 21. Acc Chem Res. 2024. PMID: 38905487 Free PMC article.

References

    1. Westheimer F. H. Science. 1987;235:1173–1178. doi: 10.1126/science.2434996. - DOI - PubMed
    1. Kim S. Bhandari R. Brearley C. A. Saiardi A. Trends Biochem. Sci. 2024;49:969–985. doi: 10.1016/j.tibs.2024.08.005. - DOI - PubMed
    1. Nguyen Trung M. Furkert D. Fiedler D. Curr. Opin. Chem. Biol. 2022;70:102177. doi: 10.1016/j.cbpa.2022.102177. - DOI - PubMed
    1. Posor Y. Jang W. Haucke V. Nat. Rev. Mol. Cell Biol. 2022;23:797–816. doi: 10.1038/s41580-022-00490-x. - DOI - PMC - PubMed
    1. Riemer E. Pullagurla N. J. Yadav R. Rana P. Jessen H. J. Kamleitner M. Schaaf G. Laha D. Front. Plant Sci. 2022;13:1–18. - PMC - PubMed

LinkOut - more resources